Mulmit

CASTLE BIOSCIENCES INCCASTLE BIOSCIENCES INC

CSTL Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31344,229,000-42,810,000-24,158,000-0.83
2024-12-31332,069,0008,670,00018,245,0000.62
2023-12-31219,788,000-67,977,000-57,466,000-2.14
2022-12-31137,039,000-72,855,000-67,138,000-2.58
2021-12-3194,085,000-40,079,000-31,292,000-1.24

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01Oelschlager Kristen MChief Operating Officer4,152
2026-09-01Oelschlager Kristen MChief Operating Officer3,952
2026-09-01Oelschlager Kristen MChief Operating Officer200
2026-09-01Oelschlager Kristen MChief Operating Officer4,152
2026-08-31Juvenal Tobin WChief Commercial Officer1,730
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer12,428
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer11,472
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer2,505
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer2,129
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer257
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer257
2026-08-28MAETZOLD DEREK JPres. & Chief Exec. Officer257

8-K events

FiledItems
2026-07-30Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-05-29Submission of matters to a vote
2026-05-06Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-02-26Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-01-13Results of operations · Regulation FD disclosure · Financial statements and exhibits
2025-11-03Results of operations · Regulation FD disclosure · Financial statements and exhibits
2025-08-08Amendments to charter or bylaws
2025-08-04Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Services-Medical Laboratories — 같은 업종, 그리고 규모가 비슷한 기업Services-Medical Laboratories — and other companies of a similar size

SEC가 같은 업종(Services-Medical Laboratories)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Services-Medical Laboratories) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.